We are live on
!
Find out more
VFA
Virtus Fund Advisers Portfolio holdings
AUM
$32.1M
1-Year Est. Return
39.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$489M
(-4.6%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
11.15%
Holding
560
New
32
Increased
113
Reduced
251
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$78.6M |
| 2 |
Halliburton
HAL
|
+$65.7M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$64.4M |
| 4 |
Campbell Soup
CPB
|
+$62M |
| 5 |
Perrigo
PRGO
|
+$58.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fair Isaac
FICO
|
+$176M |
| 2 |
Cigna
CI
|
+$122M |
| 3 |
ExxonMobil
XOM
|
+$111M |
| 4 |
Willis Towers Watson
WTW
|
+$108M |
| 5 |
Ralph Lauren
RL
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.1% |
| 2 | Industrials | 14.51% |
| 3 | Technology | 10.22% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Energy | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Teledyne Technologies
TDY
$29.2B
| $417K | ﹤0.01% |
3,126
-93
| -3% | -$12.1K |
|
327
Supernus Pharmaceuticals
SUPN
$2.7B
| $415K | ﹤0.01% |
9,628
-287
| -3% | -$10.2K |
|
|
328
ExxonMobil
XOM
$650B
| $406K | ﹤0.01% |
5,063
-1,359,644
| -100% | -$111M |
|
329
AbbVie
ABBV
$465B
| $400K | ﹤0.01% |
5,555
| – | – |
|
|
OCLR
330
DELISTED
Oclaro Inc.
OCLR
| $395K | ﹤0.01% |
41,323
-1,234
| -3% | -$11.2K |
|
331
8x8 Inc
EGHT
$279M
| $393K | ﹤0.01% |
27,106
-809
| -3% | -$11.5K |
|
332
Intel
INTC
$413B
| $389K | ﹤0.01% |
11,478
-164,916
| -93% | -$5.9M |
|
|
IDTI
333
DELISTED
Integrated Device Technology I
IDTI
| $389K | ﹤0.01% |
15,026
-448
| -3% | -$10.9K |
|
334
Paycom
PAYC
$7.88B
| $384K | ﹤0.01% |
5,675
-169
| -3% | -$10.9K |
|
|
BECN
335
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $383K | ﹤0.01% |
7,837
-2,185
| -22% | -$107K |
|
336
Mercury Systems
MRCY
$5.41B
| $381K | ﹤0.01% |
+8,757
| New | +$344K |
|
337
Rogers Corp
ROG
$2.08B
| $381K | ﹤0.01% |
+3,376
| New | +$342K |
|
|
COHR
338
DELISTED
Coherent Inc
COHR
| $381K | ﹤0.01% |
1,612
-1,460
| -48% | -$335K |
|
339
Employers Holdings
EIG
$907M
| $380K | ﹤0.01% |
8,779
-6,167
| -41% | -$248K |
|
340
Chemed
CHE
$7.16B
| $379K | ﹤0.01% |
1,849
-768
| -29% | -$153K |
|
|
RDUS
341
DELISTED
Radius Health, Inc.
RDUS
| $377K | ﹤0.01% |
8,142
-243
| -3% | -$9.29K |
|
|
VSM
342
DELISTED
Versum Materials, Inc.
VSM
| $377K | ﹤0.01% |
11,892
-355
| -3% | -$11.1K |
|
343
UFP Industries
UFPI
$4.95B
| $375K | ﹤0.01% |
13,002
-387
| -3% | -$11.8K |
|
344
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
| $373K | ﹤0.01% |
3,044
-202
| -6% | -$25K |
|
|
LOGM
345
DELISTED
LogMein, Inc.
LOGM
| $369K | ﹤0.01% |
3,440
-102
| -3% | -$11.2K |
|
346
Monolithic Power Systems
MPWR
$61.4B
| $367K | ﹤0.01% |
3,736
-111
| -3% | -$10.6K |
|
|
NXTM
347
DELISTED
NxStage Medical Inc.
NXTM
| $366K | ﹤0.01% |
14,603
-6,326
| -30% | -$157K |
|
|
RAI
348
DELISTED
Reynolds American Inc
RAI
| $366K | ﹤0.01% |
5,660
| – | – |
|
349
Franklin Electric
FELE
$4.66B
| $364K | ﹤0.01% |
8,858
-264
| -3% | -$10.6K |
|
|
DENN
350
DELISTED
Denny's
DENN
| $352K | ﹤0.01% |
30,134
-899
| -3% | -$10.8K |
|
Similar funds
VCM
CGI
SFM
CIA
SL
OAM
MFAM
AH
Virtus Fund Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, Virtus Fund Advisers held 560 positions worth $10.1B, down 4.6% from $10.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus Fund Advisers withdrew a net $516M in Q2 2017, closing 39 positions and reducing 251 holdings. Its most notable exit was Willis Towers Watson, an estimated $108M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, Virtus Fund Advisers opened a new position in Campbell Soup worth $56.5M.
- Virtus Fund Advisers's largest Q2 2017 buy was Campbell Soup: 1,095,493 shares worth $56.5M.
- Virtus Fund Advisers added most to Zimmer Biomet in Q2 2017, an estimated $78.6M increase.
- Virtus Fund Advisers's biggest Q2 2017 reduction was Fair Isaac, cutting an estimated $176M.
- Virtus Fund Advisers fully exited Willis Towers Watson in Q2 2017, selling an estimated $108M.
- Virtus Fund Advisers's ten largest holdings make up 11% of its $10.1B portfolio in Q2 2017.
- Virtus Fund Advisers opened 32 new positions and closed 39 in Q2 2017.
- Virtus Fund Advisers's portfolio value fell 4.6% quarter-over-quarter to $10.1B.
Based on Virtus Fund Advisers's 13F filing for Q2 2017, filed 11 Aug 2017.